26-Year-Old Woman with Rare and Life-Threating Pregnancy Tumour successfully treated at Fortis Hospital Nagarbhavi

▴ Fortis Hospital Nagarbhavi
Rare Pregnancy Tumors are reported in 2 out of every 1000 Pregnancies.

Bengaluru, 15 January 2026: Doctors at Fortis Hospital, Nagarbhavi successfully treated a Life-threatening pregnancy-related tumour in a 26-year-old woman, while preserving her uterus and fertility. The patient was diagnosed with Gestational Trophoblastic Neoplasia - a rare pregnancy-related tumour characterized by abnormal tissue growth inside the uterus. The tumor posed a high risk of sudden, severe internal bleeding if not handled with extreme caution. The rare case was managed through a multi-disciplinary approach led by Dr. Nirmala Chandrashekar, Consultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi.

When admitted at Fortis Nagarbhavi, the patient was presented with complaints of missed abortion (a type of miscarriage where the pregnancy has stopped developing) and continuous vaginal spotting. Her ultrasound scans showed abnormal intrauterine mass with significantly increased blood flow. In such cases, emergency removal of the uterus becomes necessary to save the patient’s life. Given the gravity of the situation, the patient’s family initially requested hysterectomy. However, after thorough evaluation, the Fortis Nagarbhavi medical team opted for a carefully planned, step-by-step conservative approach aimed at preserving the patient’s fertility.

The team of doctors, first performed a procedure to temporarily block blood supply to the uterus, significantly reducing the risk of massive bleeding. This was followed by a meticulously monitored removal of the abnormal tissue under ultrasound guidance. The patient responded well to the treatment, experienced no major complications, and recovered smoothly. Subsequent tests confirmed a partial molar pregnancy, a rare but treatable condition. After treatment, the patient’s pregnancy hormone levels returned to normal, confirming complete recovery without the need for uterus removal.

Giving details of the case, Dr Nirmala ChandrashekarConsultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi said, “This was an extremely challenging case due to the high risk of sudden and severe bleeding. Our foremost priority was to save the patient’s life while making every possible effort to preserve her uterus. By carefully reducing uterine blood flow first and then removing the abnormal tissue under ultrasound guidance, we were able to achieve a safe and fertility-preserving outcome.”

Expressing her gratitude, the patient said, “I feared the worst, but I never imagined it could be so serious. The doctors at Fortis Nagarbhavi explained everything patiently and treated me with great care. I am deeply grateful that my life was saved and that my ability to have children in the future has been conserved.”

Mr Ratheef Naik, Facility Director, Fortis Hospital, Nagarbhavi, added, “Gestational trophoblastic tumours demand early diagnosis and coordinated multidisciplinary expertise. At Fortis Nagarbhavi, we are equipped to deliver advanced, conservative and fertility-preserving care when patients seek timely treatment. This successful intervention once again reinforces our position as a leading tertiary care centre for managing high-risk and complex obstetric conditions, combining clinical excellence with compassionate, patient-centric care.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026